BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 12628075)

  • 1. Zollinger-Ellison Syndrome.
    Hung PD; Schubert ML; Mihas AA
    Curr Treat Options Gastroenterol; 2003 Apr; 6(2):163-170. PubMed ID: 12628075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
    Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
    J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
    Banasch M; Schmitz F
    Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with Zollinger-Ellison syndrome.
    Meko JB; Norton JA
    Annu Rev Med; 1995; 46():395-411. PubMed ID: 7598474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
    Richards ML; Gauger P; Thompson NW; Giordano TJ
    World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
    Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
    Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.
    Rossi RE; Elvevi A; Citterio D; Coppa J; Invernizzi P; Mazzaferro V; Massironi S
    World J Gastroenterol; 2021 Sep; 27(35):5890-5907. PubMed ID: 34629807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zollinger-Ellison syndrome. Clinical presentation in 261 patients.
    Roy PK; Venzon DJ; Shojamanesh H; Abou-Saif A; Peghini P; Doppman JL; Gibril F; Jensen RT
    Medicine (Baltimore); 2000 Nov; 79(6):379-411. PubMed ID: 11144036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zollinger-Ellison syndrome. Diagnosis and therapy.
    Campana D; Piscitelli L; Mazzotta E; Bonora M; Serra C; Salomone L; Corinaldesi R; Tomassetti P
    Minerva Med; 2005 Jun; 96(3):187-206. PubMed ID: 16175161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
    Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
    World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
    Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
    Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
    Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
    Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zollinger-Ellison syndrome in 2006: concepts from a clinical point of view.
    Pellicano R; De Angelis C; Resegotti A; Rizzetto M
    Panminerva Med; 2006 Mar; 48(1):33-40. PubMed ID: 16633330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zollinger Ellison Syndrome Refractory to Medical Therapy in the Setting of Multiple Endocrine Neoplasia Type I.
    Martino BR; Manibusan P
    Cureus; 2022 Jun; 14(6):e26468. PubMed ID: 35919366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zollinger-Ellison syndrome: pathogenesis, diagnosis, and management.
    Hirschowitz BI
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):44S-48S; discussion 49S-50S. PubMed ID: 9127626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case presentation of gastrinoma combined with gastric carcinoid with the longest survival record -- Zollinger-Ellison syndrome: pathophysiology, diagnosis and therapy.
    Konturek SJ; Konturek PC; Bielański W; Lorens K; Sito E; Konturek JW; Kwiecień S; Bobrzyński A; Pawlik T; Karcz D; Areny H; Stachura T
    Med Sci Monit; 2002 Jun; 8(6):CS43-59. PubMed ID: 12070442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric enterochromaffin-like cell changes in multiple endocrine neoplasia type 1.
    Manoharan J; Anlauf M; Albers MB; Denzer UW; Mintziras I; Wächter S; Di Fazio P; Bollmann C; Bartsch DK
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):439-446. PubMed ID: 33506527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zollinger-Ellison syndrome: a clinical update.
    Marshall JB; Settles RH
    Postgrad Med; 1980 Jul; 68(1):38-41, 45-6, 49-50. PubMed ID: 7393784
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.